Group 1 - The core viewpoint of the news is that Haoyue Nursing has seen a stock price increase of 5.07%, reaching 34.41 CNY per share, with a total market capitalization of 7.4 billion CNY [1] - Haoyue Nursing, established on March 11, 2008, and listed on September 11, 2020, specializes in the research, manufacturing, and sales of hygiene products for women, infants, and adults [1] - The revenue composition of Haoyue Nursing includes 52.90% from infant hygiene products, 36.30% from adult hygiene products, and 10.80% from other products [1] Group 2 - Among the top circulating shareholders of Haoyue Nursing, a fund under Southern Fund holds a position, specifically the Southern CSI 1000 ETF (512100), which reduced its holdings by 11,300 shares in the third quarter [2] - The Southern CSI 1000 ETF (512100) has a current scale of 76.63 billion CNY and has achieved a year-to-date return of 26.51%, ranking 1845 out of 4208 in its category [2] - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 7 years and 14 days, with a total asset scale of 122.76 billion CNY [3]

Core Insights - The personal care products sector experienced a decline of 0.31% on November 18, with Zhongshun Jierou leading the drop [1] - The Shanghai Composite Index closed at 3939.81, down 0.81%, while the Shenzhen Component Index closed at 13080.49, down 0.92% [1] Stock Performance Summary - Yanjing Co. (300658) closed at 10.89, up 2.74% with a trading volume of 399,700 shares and a transaction value of 418 million yuan [1] - Yiyi Co. (001206) closed at 32.05, up 2.30% with a trading volume of 53,000 shares and a transaction value of 168 million yuan [1] - Ziya Co. (003006) closed at 22.07, up 1.89% with a trading volume of 53,100 shares and a transaction value of 118 million yuan [1] - Other notable declines include Zhongshun Jierou (002511) down 1.54% and Liangmian Needle (600249) down 1.46% [2] Capital Flow Analysis - The personal care products sector saw a net outflow of 37.87 million yuan from institutional investors, while retail investors contributed a net inflow of 23.98 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2][3] Individual Stock Capital Flow - Yanjing Co. (300658) had a net inflow of 27.09 million yuan from institutional investors, while retail investors had a net outflow of 20.66 million yuan [3] - Zhongshun Jierou (002511) experienced a significant net outflow of 9.94 million yuan from institutional investors, but retail investors contributed a net inflow of 6.10 million yuan [3] - Other companies like Jiya Co. (301009) and Luxi Co. (605009) also showed varied capital flows, indicating differing investor sentiments across the sector [3]

Core Insights - The personal care products sector experienced a decline of 0.71% on November 17, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Yanjing Co., Ltd. saw a significant increase of 10.42%, closing at 10.60 with a trading volume of 403,600 shares and a transaction value of 416 million yuan [1] - Other notable performers included Yiyi Co., Ltd. with a 1.13% increase and Kela Co., Ltd. with a 0.98% increase [1] - Baiya Co., Ltd. led the decline with a drop of 2.70%, closing at 21.66 with a trading volume of 63,000 shares and a transaction value of 137 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 67.19 million yuan from institutional investors, while retail investors contributed a net inflow of 26.53 million yuan [2] - The capital flow data indicates that Yanjing Co., Ltd. had a net inflow of 32.94 million yuan from institutional investors, while Baiya Co., Ltd. experienced a net outflow of 5.45 million yuan [3]

Group 1: Core Insights - The North American personal care market is experiencing intensified competition, with Procter & Gamble showing better profitability compared to revenue, while Kimberly-Clark is seeing efficiency improvements from its transformation efforts [1][2] - In the domestic market, upstream supply chain companies such as Yanjian, Jieya, and Nuobang have reported significant revenue growth of 17%, 107%, and 23% respectively, indicating a recovery in overseas orders [1][3] Group 2: Company Performance - Procter & Gamble reported global revenue of $22.39 billion and net profit of $4.75 billion for FY26Q1, reflecting a year-on-year increase of 3% and 20% respectively, with challenges in the North American market [2] - Kimberly-Clark's Q3 revenue reached $4.15 billion, with a net profit of $450 million, showing a slight revenue increase but a significant decline in net profit due to transformation costs [2] Group 3: Market Trends - The domestic personal care market is facing fierce competition, leading to increased sales expenses and weaker profit growth compared to revenue for many companies [3] - The upgrade of global disposable hygiene materials is accelerating, with a shift from internal competition to external expansion, particularly in the non-woven fabric supply chain [4] Group 4: Investment Recommendations - Companies with established global supply chain layouts, such as Yanjian, are recommended for investment due to the ongoing upgrade trend in overseas hygiene products [4] - Jieya is expected to benefit from increased orders in its wet wipes business, while Sturdy Medical is noted for its stable profitability amid diverse business growth [4]

Core Viewpoint - The company, Hangzhou Haoyue Nursing Products Co., Ltd., announced the repurchase and cancellation of restricted stocks due to the departure of an incentive recipient, in accordance with its stock incentive plan and relevant regulations [2][4]. Group 1: Repurchase and Cancellation Details - The repurchase and cancellation of restricted stocks involves one incentive recipient who no longer qualifies due to resignation, leading to the decision to repurchase 1,680 shares at an adjusted price of 18.94 yuan per share [4][5]. - The company held board and supervisory meetings on April 14, 2025, to approve the repurchase plan, and no objections were raised by creditors during the 45-day notice period [3][4]. - Following the repurchase, the total number of shares will decrease from 215,067,640 to 215,065,960 [7]. Group 2: Governance and Board Changes - Due to internal governance adjustments, Mr. Yu Jinhong resigned from his positions as a board member and vice general manager on November 13, 2025, which will not affect the board's operational capacity [12]. - Mr. Yu was subsequently elected as a worker representative director on November 14, 2025, ensuring compliance with legal requirements regarding board composition [12][13].

证券代码：605009 证券简称：豪悦护理 公告编号：2025-059 杭州豪悦护理用品股份有限公司 关于股权激励限制性股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购注销原因：杭州豪悦护理用品股份有限公司（以下简称"公司"）根 据《2021 年限制性股票激励计划（草案）》（以下简称"《激励计划》"）相关规定 以及 2021 年第二次临时股东大会的授权，首次授予的激励对象中 1 名激励对象 因离职而不再具备激励对象资格，公司决定将其持有的已获授但尚未解除限售的 限制性股票进行回购并注销。 本次注销股份的有关情况 | 回购股份数量（股） | 注销股份数量（股） | 注销日期 | | --- | --- | --- | | 1,680 | 1,680 | 2025-11-19 | 一、本次限制性股票回购注销的决策与信息披露 二、本次限制性股票回购注销情况 （一）本次回购注销限制性股票的原因及依据 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）等相关 法律规定，以及公司《激励计 ...

Core Viewpoint - Haoyue Care announced the election of Mr. Yu Jinhong as the employee representative director of the company's third board of directors [2] Group 1 - The announcement was made on the evening of November 14 [2] - The election reflects the company's governance structure and employee representation [2]

Core Points - The company announced the repurchase and cancellation of 1,680 shares of restricted stock due to one incentive recipient's departure from the company [2] - The cancellation date for the shares is set for November 19, 2025 [2] Summary by Category Company Actions - The company decided to repurchase and cancel restricted stock held by a departing incentive recipient [2] - The number of shares being canceled is 1,680 [2] - The action is in accordance with the provisions of the 2021 Restricted Stock Incentive Plan and the authorization from the second extraordinary general meeting of shareholders in 2021 [2] Future Implications - The cancellation of shares will take effect on November 19, 2025 [2]

证券代码：605009 证券简称：豪悦护理 公告编号：2025-058 杭州豪悦护理用品股份有限公司 二、职工代表董事选举情况 根据《中华人民共和国公司法》《上市公司章程指引》等法律、法规和规范 性文件以及《杭州豪悦护理用品股份有限公司章程》的相关规定，公司董事会成 员中应包含一名职工代表董事。 公司于2025年11月14日召开职工代表大会，经全体与会职工代表表决，同意 选举虞进洪先生（简历详见附件）为公司第三届董事会职工代表董事，与经公司 股东大会选举产生的第三届董事会非职工代表董事共同组成公司第三届董事会， 任期自公司职工代表大会选举通过之日起至公司第三届董事会任期届满之日止。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事离任情况 （一）提前离任的基本情况 | | | | 原定任期 | | 是否继续在上 | 具体职务（如适 | 是否存在未 | | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 | 离任时间 | 到期日 | 离任原因 | 市 ...

国浩律师（杭州）事务所 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二五年十一月 国浩律师（杭州）事务所 法律意见书 关于 杭州豪悦护理用品股份有限公司 2021 年限制性股票回购注销相关事项 之 法律意见书 国浩律师（杭州）事务所 关于杭州豪悦护理用品股份有限公司 2021 年限制性股票回购注销相关事项之 法律意见书 致：杭州豪悦护理用品股份有限公司 根据杭州豪悦护理用品股份有限公司（以下简称"豪悦护理"或"公司"） 与国浩律师（杭州）事务所（以下简称"本所"）签订的专项法律服务委托协议， 本所 ...